ZentMed Co., Ltd. ( "ZentMed") was established in 2019. With over 30 years of experience in solid-state microwave technology, the company's microwave technology team is dedicated to transforming advanced military microwave technology into medical applications, creating high-precision, high-efficiency microwave ablation systems.
The company's core product, the solid-state microwave ablation system, utilizes a self-developed solid-state microwave source, featuring ultra-low VSWR (≤2.8), intelligent load identification, wide-range temperature measurement (down to 30℃), and efficient water-cooling design. This enables precise control and directional release of microwave energy, effectively avoiding tissue carbonization and adhesion, and improving surgical safety and efficacy.
Currently, microwave ablation technology is widely used in many clinical fields such as thyroid nodules, liver tumors, lung nodules, breast tumors, uterine fibroids, gastrointestinal tumors, and animal tumors. Adhering to an industrialization strategy of "from easy to difficult, tiered development," the company continuously promotes the innovation and application of microwave ablation technology in minimally invasive interventional treatments. At present, the company's research products include other energy platform products such as radiofrequency ablation and cryoablation, and is committed to becoming an innovative force and energy platform benchmark enterprise in the field of general intervention.
The company's technical team originates from the 14th Research Institute of China Electronics Technology Group Corporation, possessing top-tier domestic microwave technology backgrounds and over 30 years of experience in medical-engineering integration. The operations team has a multinational corporate background, ensuring the professionalism and internationalization of product development and market services.
Striving for excellence in technology, realizing the dream of health. ZentMed safeguards life with technology and defines the future with precision.
